APA (7th ed.) Citation

Moore, C. L., Turkova, A., Mujuru, H., Kekitiinwa, A., Lugemwa, A., Kityo, C. M., . . . Musiime, V. (2021). ODYSSEY clinical trial design: A randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing. BMC Infectious Diseases, 21(1), 1. https://doi.org/10.1186/s12879-020-05672-6

Chicago Style (17th ed.) Citation

Moore, Cecilia L., et al. "ODYSSEY Clinical Trial Design: A Randomised Global Study to Evaluate the Efficacy and Safety of Dolutegravir-based Antiretroviral Therapy in HIV-positive Children, with Nested Pharmacokinetic Sub-studies to Evaluate Pragmatic WHO-weight-band Based Dolutegravir Dosing." BMC Infectious Diseases 21, no. 1 (2021): 1. https://doi.org/10.1186/s12879-020-05672-6.

MLA (9th ed.) Citation

Moore, Cecilia L., et al. "ODYSSEY Clinical Trial Design: A Randomised Global Study to Evaluate the Efficacy and Safety of Dolutegravir-based Antiretroviral Therapy in HIV-positive Children, with Nested Pharmacokinetic Sub-studies to Evaluate Pragmatic WHO-weight-band Based Dolutegravir Dosing." BMC Infectious Diseases, vol. 21, no. 1, 2021, p. 1, https://doi.org/10.1186/s12879-020-05672-6.